Atıf Formatları
Increased sTRAIL levels were correlated with patient survival in BevacizumAb treated metastatic colon cancer patients
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. BISGIN Et Al. , "Increased sTRAIL levels were correlated with patient survival in BevacizumAb treated metastatic colon cancer patients," Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research , vol.20, Hannover, Germany, pp.1417, 2009

BISGIN, A. Et Al. 2009. Increased sTRAIL levels were correlated with patient survival in BevacizumAb treated metastatic colon cancer patients. Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research , (Hannover, Germany), 1417.

BISGIN, A., KARGI, A., YALCIN, A., AYDIN, C., SAVAS, B., & ŞANLIOĞLU, S., (2009). Increased sTRAIL levels were correlated with patient survival in BevacizumAb treated metastatic colon cancer patients . Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research (pp.1417). Hannover, Germany

BISGIN, Atil Et Al. "Increased sTRAIL levels were correlated with patient survival in BevacizumAb treated metastatic colon cancer patients," Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Germany, 2009

BISGIN, Atil Et Al. "Increased sTRAIL levels were correlated with patient survival in BevacizumAb treated metastatic colon cancer patients." Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research , Hannover, Germany, pp.1417, 2009

BISGIN, A. Et Al. (2009) . "Increased sTRAIL levels were correlated with patient survival in BevacizumAb treated metastatic colon cancer patients." Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research , Hannover, Germany, p.1417.

@conferencepaper{conferencepaper, author={Atil BISGIN Et Al. }, title={Increased sTRAIL levels were correlated with patient survival in BevacizumAb treated metastatic colon cancer patients}, congress name={Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research}, city={Hannover}, country={Germany}, year={2009}, pages={1417} }